Delivery Order SPE2DB22D1106-SPE2DB25FFAV2
- Not listed
- The Defense Logistics Agency awarded a $5,525.16 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Onfil 10 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance through July 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,051.40 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for ultimate completion on July 22, 2025, with performance taking place at the vendor's Conshohocken facility. The award was competitively procured with no...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,404.40 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-competitive award under an existing indefinite delivery contract vehicle. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by July 22, 2025. The award is categorized as a child contract, indicating it derives from a larger contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $126,357.40 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price, competitively awarded contract has an ultimate completion date of July 25, 2025, and represents a child order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order carries no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,262.65 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 1, 2025. The delivery order represents a child contract under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical, which holds a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,315.28 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for ultimate completion on July 23, 2025. The award was made through open competition with no set-aside designation and involves...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,869.95 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025. This firm fixed-price, competitively awarded contract (No. 4568856631) carries an ultimate completion date of July 23, 2025, and represents a child order under the company's larger indefinite delivery contract vehicle. The award includes no set-aside designation,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,584.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The delivery order will be fulfilled at...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAV2Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for Onfil 10 mg tablets (100-count units) with a ceiling value of $11,281.66. This firm fixed-price delivery order, which represents a non-competitive set-aside contract, is scheduled for ultimate completion by August 1, 2025, with performance occurring at the awardee's Conshohocken facility. The contract was issued as a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company holds a substantial prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which enables the delivery of a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. This delivery order demonstrates the company's ongoing role as a key vendor in the DLA's pharmaceutical supply chain, fulfilling recurring medical procurement needs across the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 7/31/25 |